• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接种 SARS-CoV-2 疫苗后的亚急性甲状腺炎:对已描述病例的回顾及个人经验。

Subacute thyroiditis after SARS-Cov2 vaccination: A review of the cases being described and personal experience.

机构信息

Department of General, Visceral, Cancer and Transplant Surgery, University Clinic of Cologne, Cologne, Germany.

Policlinic for Endocrinology, Diabetes and Prevention Medicine, University Clinic of Cologne, Cologne, Germany.

出版信息

Endocr Regul. 2022 Jul 13;56(3):227-231. doi: 10.2478/enr-2022-0024.

DOI:10.2478/enr-2022-0024
PMID:35843718
Abstract

The present study evaluates the occurrence of subacute thyroiditis in temporal connection with SARS-Cov2 vaccinations described in the literature last year and confirmed by our clinical routine. Systematic literature search in Medline for studies reporting diagnosis of subacute thyroiditis in temporal connection with vaccinations against Covid 19. The literature search yielded 24 relevant references out of which 22 were "case reports" and two "Letters to the Editor" and encompassed 37 patient cases, in total. They had received a SARS-Cov2 vaccination shortly before the diagnosis (median interval to vaccination six days). In none of these cases, infection of the upper respiratory tract had previously been identified as a classic trigger of the disease. Newly occurring hyperthyroidism and increased laboratory signs of inflammation were described in 78% and 74% of cases, respectively. Atypical clinical pictures (asymptomatic, euthyroid, no inflammation marks) have been observed in both the literature and our patients suspected of thyroid cancer referred to surgery. In times of pandemics and the resulting vaccination, new rapidly occurring sonographic changes in the thyroid gland should be revaluated after 2-3 weeks, or recommended to undergo a fine-needle biopsy, in order to avoid unnecessary surgical interventions.

摘要

本研究评估了去年文献中描述的与 SARS-CoV-2 疫苗接种相关的亚急性甲状腺炎的发生情况,并通过我们的临床常规得到了证实。在 Medline 中进行系统的文献检索,以查找报告与接种 COVID-19 疫苗有时间关联的亚急性甲状腺炎诊断的研究。文献检索共得到 24 篇相关参考文献,其中 22 篇为“病例报告”,2 篇为“给编辑的信”,共涉及 37 例患者。他们在诊断前不久接种了 SARS-CoV-2 疫苗(接种至发病的中位间隔为 6 天)。在这些病例中,没有一例先前被确定为上呼吸道感染为该病的经典诱因。新出现的甲状腺功能亢进和实验室炎症标志物升高分别在 78%和 74%的病例中被描述。在文献和我们怀疑患有甲状腺癌而转诊手术的患者中,都观察到了典型的临床症状(无症状、甲状腺功能正常、无炎症标志物)。在大流行期间以及由此产生的疫苗接种中,对于甲状腺内新出现的快速超声变化,应在 2-3 周后重新评估,或建议进行细针活检,以避免不必要的手术干预。

相似文献

1
Subacute thyroiditis after SARS-Cov2 vaccination: A review of the cases being described and personal experience.接种 SARS-CoV-2 疫苗后的亚急性甲状腺炎:对已描述病例的回顾及个人经验。
Endocr Regul. 2022 Jul 13;56(3):227-231. doi: 10.2478/enr-2022-0024.
2
Subacute thyroiditis after vaccination against SARS-CoV-2.接种新型冠状病毒疫苗后发生的亚急性甲状腺炎。
Tidsskr Nor Laegeforen. 2021 Oct 11;141(2021-14). doi: 10.4045/tidsskr.21.0554. Print 2021 Oct 12.
3
Subacute thyroiditis following COVID-19 vaccination in a 67-year-old male patient: a case report.67 岁男性患者接种 COVID-19 疫苗后发生亚急性甲状腺炎:病例报告。
Hum Vaccin Immunother. 2021 Nov 2;17(11):4090-4092. doi: 10.1080/21645515.2021.1947102. Epub 2021 Jul 1.
4
Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine: Postvaccination ASIA Syndrome.三例接种 SARS-CoV-2 疫苗后亚急性甲状腺炎:疫苗接种后 ASIA 综合征。
J Clin Endocrinol Metab. 2021 Aug 18;106(9):2600-2605. doi: 10.1210/clinem/dgab373.
5
Subacute thyroiditis following COVID-19 vaccination: Case presentation.接种 COVID-19 疫苗后的亚急性甲状腺炎:病例报告。
Antivir Ther. 2023 Oct;28(5):13596535231208831. doi: 10.1177/13596535231208831.
6
Silent thyroiditis following vaccination against COVID-19: report of two cases.接种 COVID-19 疫苗后发生静默性甲状腺炎:两例报告。
J Endocrinol Invest. 2022 May;45(5):1079-1083. doi: 10.1007/s40618-021-01725-y. Epub 2022 Jan 16.
7
Thyroid Inconveniences With Vaccination Against SARS-CoV-2: The Size of the Matter. A Systematic Review.甲状腺与接种 SARS-CoV-2 疫苗的不适反应:问题的大小。系统综述。
Front Endocrinol (Lausanne). 2022 Jun 23;13:900964. doi: 10.3389/fendo.2022.900964. eCollection 2022.
8
Autoimmune and inflammatory thyroid diseases following vaccination with SARS-CoV-2 vaccines: from etiopathogenesis to clinical management.自身免疫和炎症性甲状腺疾病与 SARS-CoV-2 疫苗接种相关:从发病机制到临床管理。
Endocrine. 2022 Dec;78(3):406-417. doi: 10.1007/s12020-022-03118-4. Epub 2022 Jun 28.
9
Thyrotoxicosis following SARS-COV-2 vaccination: a case series and discussion.接种 SARS-COV-2 疫苗后发生甲状腺毒症:病例系列及讨论。
J Endocrinol Invest. 2022 May;45(5):1071-1077. doi: 10.1007/s40618-022-01739-0. Epub 2022 Jan 11.
10
Is Subacute Thyroiditis an Underestimated Manifestation of SARS-CoV-2 Infection? Insights From a Case Series.亚急性甲状腺炎是 SARS-CoV-2 感染的被低估表现吗?一项病例系列研究的启示。
J Clin Endocrinol Metab. 2020 Oct 1;105(10). doi: 10.1210/clinem/dgaa537.

引用本文的文献

1
Clinical Aspects in Subacute Thyroiditis: A Real-Life Study on 226 Cases in Greece Amid the COVID-19 Pandemic.亚急性甲状腺炎的临床情况:希腊在新冠疫情期间对226例病例的实际研究
J Clin Med. 2023 Nov 18;12(22):7171. doi: 10.3390/jcm12227171.